Therapeutic targets in the nitrogen mustard sensitivity of B-cell chronic lymphocyte leukemia (B-CLL)

被引：0
|
作者：
Kannan, Subburaj [1 ]
机构：
[1] SW Texas Jr Coll, Dept Biol, Eagle Pass, TX 78852 USA
来源：
MEDICAL HYPOTHESES | 2006年 / 67卷 / 04期
关键词：
D O I：
10.1016/j.mehy.2006.04.014
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：998 / 998
页数：1
相关论文
共 50 条
  • [21] The relationship between karyotype and lymphocyte morphology in B-chronic lymphocytic leukemia (B-CLL)
    Kroft, SH
    Finn, WG
    Kay, NE
    Peterson, LC
    LABORATORY INVESTIGATION, 1996, 74 (01) : 667 - 667
  • [22] CONTROL OF B-LYMPHOCYTE PROLIFERATION BY TRANSFORMING GROWTH-FACTOR-BETA (TGF-B) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    LAGNEAUX, L
    DELFORGE, A
    BRON, D
    STRYCKMANS, P
    BLOOD, 1994, 84 (10) : A526 - A526
  • [23] Multi-drug resistance in B-cell chronic lymphocytic leukemia (B-CLL): A feature of B-CLL sub-sets with poor prognosis genetic alterations?
    Rosenwald, Andreas
    LEUKEMIA & LYMPHOMA, 2006, 47 (11) : 2263 - 2264
  • [24] Allogeneic stem cell transplantation from related or unrelated donors for B-cell chronic lymphocytic leukemia (B-CLL).
    Pavletic, ZS
    Arrowsmith, ER
    Bierman, PJ
    Goodman, SA
    Vose, JM
    Tarantolo, SR
    Stein, RS
    Greer, JP
    Kollath, JP
    Weisenburger, DD
    Wolff, SN
    Armitage, JO
    Bishop, MR
    BLOOD, 1998, 92 (10) : 288A - 288A
  • [25] Reconstitution of the T cell repertoire following treatment with alemtuzumab in patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Rezvany, MR
    Tehrani, MJ
    Karlsson, C
    Lundin, J
    Rabbani, H
    Mellstedt, K
    Österborg, A
    BLOOD, 2005, 106 (11) : 837A - 837A
  • [26] Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Dzietczenia, J.
    Wrobel, T.
    Jazwiec, B.
    Mazur, G.
    Butrym, A.
    Poreba, R.
    Kuliczkowski, K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (06) : E217 - E221
  • [27] In vitro and in vivo cytotoxicity of fludarabine in patients with advanced stage B-cell chronic lymphocytic leukemia (B-CLL)
    Hilgenfeld, E
    Knauf, WU
    Thiel, E
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 245 - 253
  • [28] CD31 expression and gene polymorphisms in patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Mainou-Fowler, Tryfonia
    Norden, Jean
    Porteous, Alistair
    Davies, Sian
    Middleton, Peter
    Nicolle, Annette
    Proctor, Stephen
    Dickinson, Anne
    Summerfield, Geoffrey
    BLOOD, 2006, 108 (11) : 322B - 323B
  • [29] IN-VITRO SENSITIVITY TO CAMPTOTHECINS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) WITH AND WITHOUT P53-GENE MUTATION
    COSTIN, D
    POTMESIL, M
    NEWCOMB, EW
    ELROUBY, S
    THOMAS, A
    DRYGAS, J
    MORSE, L
    SILBER, R
    BLOOD, 1993, 82 (10) : A43 - A43
  • [30] Hepatitis B virus (HBV) reactivation in HBsAg negative patients affected by B-cell chronic lymphocytic leukemia (B-CLL).
    Bernuzzi, P
    Lazzaro, A
    Arcari, A
    Anselmi, E
    Berte, R
    Civardi, G
    Moroni, CF
    Vallisa, D
    Cavanna, L
    BLOOD, 2003, 102 (11) : 351B - 351B
12345